These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6349744)

  • 1. Adjuvant chemotherapy with doxorubicin (Adriamycin) and 5-fluorouracil in T3, NX, MO bladder cancer treated with radiotherapy.
    Richards B; Bastable JR; Freedman L; Glashan RW; Harris G; Newling DW; Robinson MR; Smith PH
    Br J Urol; 1983 Aug; 55(4):386-91. PubMed ID: 6349744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A toxicity study of the treatment of T3 bladder tumours with a combination of radiotherapy and chemotherapy.
    Glashan RW; Houghton AL; Robinson MR
    Br J Urol; 1977; 49(7):669-71. PubMed ID: 597706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy with adriamycin and 5-fluorouracil in advanced bladder carcinoma.
    Veronesi A; Magri MD; Figoli F; Tirelli U; Galligioni E; Trovò MG; Merlo A; Dal Bò V; Tumolo S; Grigoletto E
    Clin Oncol; 1982 Jun; 8(2):103-6. PubMed ID: 7105520
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination chemotherapy for advanced bladder cancer with adriamycin, cyclophosphamide, and 5-fluorouracil.
    Tashiro K; Machida T; Masuda F; Ohishi Y
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S43-6. PubMed ID: 6640834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic chemotherapy with intravesical instillation of adriamycin and oral administration of 5-fluorouracil after surgery for superficial bladder cancer. The Japanese Urological Cancer Research Group for Adriamycin.
    Obata K; Ohashi Y; Akaza H; Isaka S; Kagawa S; Koiso K; Kotake T; Machida T; Matsumura Y; Niijima T
    Cancer Chemother Pharmacol; 1994; 35 Suppl():S88-92. PubMed ID: 7994795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of advanced carcinoma of the bladder with combination chemotherapy.
    McGeorge A; Hart AJ; Rundle JS; McVie JG; Calman KC
    Br J Urol; 1982 Aug; 54(4):366-8. PubMed ID: 7052188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer.
    Chen WC; Liaw CC; Chuang CK; Chen MF; Chen CS; Lin PY; Chang PL; Chu SH; Wu CT; Hong JH
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):726-33. PubMed ID: 12788178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of chemotherapy alternating with twice-a-day accelerated radiation therapy as an alternative to cystectomy in muscle infiltrating (stages T2 and T3) cancer of the bladder: preliminary results.
    Vikram B; Malamud S; Silverman P; Hecht H; Grabstald H
    J Urol; 1994 Mar; 151(3):602-4. PubMed ID: 8308967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for invasive bladder cancer.
    Uekado Y; Shinka T; Hirano A; Ohkawa T
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S24-8. PubMed ID: 3117397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical adriamycin therapy for bladder cancer. Long-term results.
    Pontes JE; Dhabuwala CB; Pierce JM
    Urology; 1984 Mar; 23(3 Suppl):35-6. PubMed ID: 6702053
    [No Abstract]   [Full Text] [Related]  

  • 12. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
    Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
    Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of infiltrating cancer of the bladder with cisplatin, fluorouracil, and concurrent radiotherapy: results of a pilot study].
    Chauvet B; Félix-Faure C; Davin JL; Berger C; Vincent P; Reboul F
    Cancer Radiother; 1998 Apr; 2 Suppl 1():77s-81s. PubMed ID: 9749084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of superficial transitional cell bladder carcinoma. Long-term results of trial comparing transurethral resection alone and adjuvant chemotherapy with Doxorubicin].
    Milonas D; Mickevicius J; Mickevicius R; Motiejūnas A; Sukys D; Gudinaviciene I
    Medicina (Kaunas); 2002; 38 Suppl 1():79-83. PubMed ID: 12556642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant intra-arterial doxorubicin chemotherapy in combination with low dose radiotherapy for the treatment of locally advanced transitional cell carcinoma of the bladder.
    Sumiyoshi Y; Yokota K; Akiyama M; Inoue Y; Yoneda F; Tsujimura H; Nakajima M; Yokozeki H; Maebayashi K
    J Urol; 1994 Aug; 152(2 Pt 1):362-6. PubMed ID: 8015072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
    Kurth KH; Bouffioux C; Sylvester R; de Pauw M
    Prog Clin Biol Res; 1988; 269():525-37. PubMed ID: 3134663
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma of urinary bladder: cause for concern.
    Connor JP; Olsson CA; Benson MC; Rapoport F; Sawczuk IS
    Urology; 1989 Dec; 34(6):353-6. PubMed ID: 2595880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
    Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17-year follow-up of a randomized prospective controlled trial of adjuvant intravesical doxorubicin in the treatment of superficial bladder cancer.
    Cheng CW; Chan PS; Chan LW; Chan CK; Ng CF; Lai MM
    Int Braz J Urol; 2005; 31(3):204-11. PubMed ID: 15992422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study.
    Hussain MH; Glass TR; Forman J; Sakr W; Smith DC; Al-Sarraf M; Jones J; Balcerzak SP; Crawford ED; Grossman HB
    J Urol; 2001 Jan; 165(1):56-60; discussion 60-1. PubMed ID: 11125363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.